Murex MX.3 Production Support Analyst — Front Office (Equity Derivatives)

The Role Responsibilities: Provide front-line production support for Murex MX.3 across pricing, risk, trade capture, workflows, market data, and interfaces Own incident triage, impact assessment, root cause analysis, and follow-up remediation Monitor logs, dashboards, schedulers, RTS feeds, and batch processes to identify and resolve issues proactively Troubleshoot pricing inconsistencies, risk/sensitivity gaps, trade enrichment failures, and interface delays Manage and track vendor cases, including evidence gathering, reproduction steps, and validation of fixes Support production releases, emergency changes, and maintenance activities with pre- and post-deployment checks Maintain SOPs, runbooks, and knowledge articles to improve operational efficiency and reduce repeat incidents Contribute to monitoring, automation, and continuous improvement initiatives to strengthen platform stability. Requirements: Strong hands-on experience supporting Murex MX.3 in a production environment Knowledge of Murex modules including eTradepad, Pricing, Simulation, Livebook, and Workflow Experience with market data components such as MDCS, RTBS, MDRS, and MDIT Strong Murex log analysis, performance troubleshooting, and Unix/Linux-based support skills Scripting experience in Python and/or Unix shell Good understanding of Murex orchestration, services, process flows, and EOD job troubleshooting SQL knowledge across Sybase, SQL Server, or Oracle Understanding of Equity Derivatives products and Greeks Strong communication, analytical, and stakeholder management skills Overall 10+ years of IT experience. 5+ years of Front Office Trading Technology support experience 3+ years of Murex MX.3 support experience preferred Ability to work effectively in a high-pressure production support environment Automation mindset and continuous improvement focus.

Apply directly on RemoteJobs.org: https://remotejobs.org/remote-jobs/murex-mx3-production-support-analyst-front-office-equity-derivatives-delan-associates